Terms: = Pancreatic cancer AND IL7R, P16871, IL-7R-alpha, CDW127, CD127, ENSG00000168685, 3575 AND Diagnosis
4 results:
1. Improved predictability of pancreatic ductal adenocarcinoma diagnosis using a blood immune cell biomarker panel developed from bulk mRNA sequencing and single-cell RNA-sequencing.
Jang SI; Lee HK; Chang EJ; Kim S; Kim SY; Hong IY; Kim JK; Lee HS; Yang J; Cho JH; Lee DK
Cancer Immunol Immunother; 2023 Aug; 72(8):2757-2768. PubMed ID: 37165046
[TBL] [Abstract] [Full Text] [Related]
2. Male BRCA mutation carriers: clinical characteristics and cancer spectrum.
Ibrahim M; Yadav S; Ogunleye F; Zakalik D
BMC Cancer; 2018 Feb; 18(1):179. PubMed ID: 29433453
[TBL] [Abstract] [Full Text] [Related]
3. Variation of cytopathologists' use of the indeterminate diagnostic categories "atypical" and "suspicious for malignancy" in the cytologic diagnosis of solid pancreatic lesions on endoscopic ultrasound-guided fine-needle aspirates.
Virk RK; Gamez R; Mehrotra S; Atieh M; Barkan GA; Wojcik EM; Pambuccian SE
Diagn Cytopathol; 2017 Jan; 45(1):3-13. PubMed ID: 27873469
[TBL] [Abstract] [Full Text] [Related]
4. Primary pancreatic lymphomas: a cytopathologic analysis of a rare malignancy.
Nayer H; Weir EG; Sheth S; Ali SZ
Cancer; 2004 Oct; 102(5):315-21. PubMed ID: 15386314
[TBL] [Abstract] [Full Text] [Related]
